Results 11 to 20 of about 2,700,197 (262)

Molecular Imaging of Microglial Activation in Amyotrophic Lateral Sclerosis [PDF]

open access: yes, 2012
There is growing evidence of activated microglia and inflammatory processes in the cerebral cortex in amyotrophic lateral sclerosis (ALS). Activated microglia is characterized by increased expression of the 18 kDa translocator protein (TSPO) in the brain
Philippe Corcia   +29 more
core   +2 more sources

Plasma Neurofilament Heavy Chain Levels Correlate to Markers of Late Stage Disease Progression and Treatment Response in SOD1(G93A) Mice that Model ALS [PDF]

open access: yes, 2012
Background: Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disorder characterised by progressive degeneration of motor neurons leading to death, typically within 3–5 years of symptom onset. The diagnosis of ALS is largely reliant
Greensmith Linda   +24 more
core   +3 more sources

Noninvasive ¹³C-octanoic acid breath test shows delayed gastric emptying in patients with amyotrophic lateral sclerosis [PDF]

open access: yes, 1999
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by progressive loss of motor neurons. However, ALS has been recognized to also involve non-motor systems.
Folwaczny, Christian   +6 more
core   +1 more source

G-CSF Prevents the Progression of Structural Disintegration of White Matter Tracts in Amyotrophic Lateral Sclerosis: A Pilot Trial [PDF]

open access: yes, 2011
Background: The hematopoietic protein Granulocyte-colony stimulating factor (G-CSF) has neuroprotective and regenerative properties. The G-CSF receptor is expressed by motoneurons, and G-CSF protects cultured motoneuronal cells from apoptosis.
Tobias Warnecke   +32 more
core   +1 more source

A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis [PDF]

open access: yes, 2009
The cause of sporadic amyotrophic lateral sclerosis (ALS) is largely unknown, but genetic factors are thought to play a significant role in determining susceptibility to motor neuron degeneration.
Sendtner, M.   +461 more
core   +2 more sources

The Peroxisome Proliferator-activated Receptor γ (PPARγ) Controls Natural Protective Mechanisms against Lipid Peroxidation in Amyotrophic Lateral Sclerosis [PDF]

open access: yes, 2012
Recent evidence highlights the peroxisome proliferator-activated receptors (PPARs) as critical neuroprotective factors in several neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS). To gain new mechanistic insights into the role of
Maggi, Adriana   +8 more
core   +1 more source

Chromosome 9 ALS and FTD locus is probably derived from a single founder. [PDF]

open access: yes, 2012
We and others have recently reported an association between amyotrophic lateral sclerosis (ALS) and single nucleotide polymorphisms on chromosome 9p21 in several populations.
Shatunov, A.   +126 more
core   +1 more source

Dysphagia as the Initial Presenting Symptom of Amyotrophic Lateral Sclerosis

open access: yesPhilippine Journal of Otolaryngology Head and Neck Surgery, 2008
Objective:  To present a case of Amyotrophic Lateral Sclerosis (ALS) with an unusual initial presentation of dysphagia. Methods: Design:  Case Report Setting:  Private tertiary university hospital Patient:  One Results:  A 78-year-old ...
Adrian F. Fernando, Antonio H. Chua
doaj   +1 more source

Induced pluripotent stem cell line derived from a sporadic amyotrophic lateral sclerosis patient

open access: yesStem Cell Research, 2020
Induced pluripotent stem cells (iPSCs) were generated from peripheral blood mononuclear cells (PBMCs) obtained from a 60-year-old female diagnosed with sporadic amyotrophic lateral sclerosis (sALS).
Baofeng Feng   +12 more
doaj   +1 more source

Human iPSC-derived motoneurons harbouring TARDBP or C9ORF72 ALS mutations are dysfunctional despite maintaining viability [PDF]

open access: yes, 2015
This work has been supported by: Motor Neurone Disease Association (G.B.M., S.C. and C.E.S.); Euan MacDonald Centre (G.B.M. and S.C.); European Research Council (L.V.); Cambridge Hospitals National Institute for Health Research Biomedical Research Center
Foster, Joshua D.   +15 more
core   +1 more source

Home - About - Disclaimer - Privacy